ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 2050
    B and T Cell Phenotypes of First Degree Relatives of RA Patients in an Indigenous North American Cohort
  • Abstract Number: 1561
    B Lymphocyte Depletion Therapy with Rituximab in Primary Sjögren’s Syndrome: Indications , Effectiveness and Ultrasonographic Response
  • Abstract Number: 180
    Back to Bedside Teaching: Completion of a Rheumatology Rotation Significantly Increases Internal Medicine Residents’ Competency and Comfort with Comprehensive Knee Examinations
  • Abstract Number: 65
    Bacteria-Derived Indole Drives Autoimmune Arthritis By Altering B Cell Glycosylation of Autoantibodies
  • Abstract Number: 2124
    Bacterial Biofilm Product Curli/Edna Induces NETs and Serum Anti-Curli/Edna Levels Correlate with Bacteriuria and Lupus Activity
  • Abstract Number: 111
    BAFF Inhibition Attenuates Fibrosis in Bleomycin-Induced Scleroderma Model Via Modulating the Regulatory and Effector B-Cell Balance
  • Abstract Number: 1908
    Bariatric Surgery Does Not Affect the Incidence of Rheumatoid Arthritis in Obese Subjects
  • Abstract Number: 1518
    Baricitinib and Tofacitinib in Real Life – Does Obesity Impact Response to Janus Kinase Inhibitor Therapy in Rheumatoid Arthritis?
  • Abstract Number: 970
    Baricitinib in Patients with Systemic Lupus Erythematosus: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
  • Abstract Number: 1894
    Baricitinib-Associated Changes in Type l Interferon Gene Signature during a 24-Week Phase-2 Clinical SLE Trial
  • Abstract Number: 546
    Baricitinib: Early Vs. Delayed Start in Patients with Rheumatoid Arthritis
  • Abstract Number: 1526
    Baseline Characteristics and Outcomes in Patients with Anemia in Clinical Studies of Tofacitinib
  • Abstract Number: 1495
    Baseline Characteristics of Methotrexate Inadequate Responder Patients with RA Who Achieved Low Disease Activity with Tofacitinib Monotherapy
  • Abstract Number: 468
    Baseline Features and Outcomes of Pediatric-Onset Discoid Lupus Erythematosus: Interim Data Analysis of a Multicenter Retrospective Cohort Study
  • Abstract Number: 2588
    Baseline Pain Severity As a Predictor of Pain Improvement Following Treatment with Tofacitinib in Psoriatic Arthritis
  • Abstract Number: 582
    Baseline Power Doppler and Multi-Biomarker Disease Activity Score Predict 12-Week Disease Activity Response to Tofacitinib
  • Abstract Number: 847
    Basic Calcium Phosphate Crystals Induce Osteoarthritis-Associated Changes in Chondrocyte Phenotype through Activation of Calcium/Calmodulin Kinase 2
  • Abstract Number: 280
    Be Fierce. Take Control.TM an Evidence-Based Digital Lupus Awareness and Education Campaign for Young Minority Women at Risk for Lupus
  • Abstract Number: 1802
    Behcet’s Disease in the Southwestern United States
  • Abstract Number: 1975
    Behcet’s Disease Lies in the “B” Holder. New Associations in Disease Susceptibility and Manifestations
  • Abstract Number: 1948
    Beliefs and Preferences for Reducing Sedentary Time in Those with Current or Past Knee Symptoms
  • Abstract Number: 2072
    Beneficial Effect of Combination Therapy of Etanercept with Non-Steroidal Anti-Inflammatory Drugs Compared to Etanercept Monotherapy in a Spondyloarthritis Animal Model
  • Abstract Number: 2537
    Benefit Study: Results of Interim Analysis of a Pan-European Observational Study to Evaluate Real-World Effectiveness of SB4 Following Transition from Originator Etanercept (ETN) in Patients with Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (AxSpA)
  • Abstract Number: 283
    Benefits Accrued through the Implementation of Telerheumatology Services
  • Abstract Number: 2511
    Benepali Switches in Clinical Practice – a Positive Single Centre Experience
  • Abstract Number: 240
    Bi-Directional Associations between “Too Much Sitting” and Self-Reported Pain in Patients with Rheumatoid Arthritis
  • Abstract Number: 1915
    Big Data Analysis of Autoimmune Diseases Induced By Cancer Immunotherapies: Identifying Pharmacological Patterns of Organ-Specific Involvement
  • Abstract Number: 550
    Biologic Discontinuation in Rheumatoid Arthritis: A Population Based Study 1999-2017
  • Abstract Number: 2866
    Biologic Refractory Disease in a Cohort Study of Children and Young People with Juvenile Idiopathic Arthritis from the United Kingdom
  • Abstract Number: 93
    Biomarkers Associating Endothelial Function in Systemic Lupus Erythematous
  • Abstract Number: 957
    Biomechanical Therapy for Osteoarthritis of the Knee: A Randomized Controlled Trial
  • Abstract Number: 2522
    Biosimilar BI 695501 and Adalimumab Reference Product (RP) Have Similar Efficacy and Safety in Patients (pts) with Moderately-to-Severely Active Rheumatoid Arthritis (RA): Long-Term Results from a Phase IIIb Extension Study (VOLTAIRE®-RAext)
  • Abstract Number: 2154
    Biosimilar Infliximab Treated-Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in France: Characteristics and Clinical Outcomes
  • Abstract Number: 2384
    Biosimilar Use in Young Adults with Juvenile Idiopathic Arthritis in Germany
  • Abstract Number: 2431
    Birth Outcomes and Disease Activity during Pregnancy in a Prospective Cohort of Women with Psoriatic Arthritis and Ankylosing Spondylitis
  • Abstract Number: 2423
    Births to Women with Systemic Lupus Erythematosus Can be Identified Accurately in the Electronic Health Record
  • Abstract Number: 2424
    Bisphosphonates during Pregnancy: A Systematic Review Sayanika Kaur MD Fellow Drexel Rheumatology, Mojdeh Khaamesi MD Resident Internal Medicine Arundathi Jayatilleke MD Program Director Drexel Rheumatology
  • Abstract Number: 2065
    Blockade of the JAK/STAT Pathway Inhibits Inflammation and Bone Formation in Two Murine Models of Spondyloarthritis
  • Abstract Number: 618
    Blood Lymphocytes Subtypes As Biomarkers for Early Identification of Optimal Responders to Anti-TNF Treatment in Rheumatoid Arthritis
  • Abstract Number: 2377
    Body Image in Rheumatic Diseases: A Systematic Review
  • Abstract Number: 2399
    Bone Density, Structure and Strength in Canadian Children and Youth with Juvenile Idiopathic Arthritis: The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis)
  • Abstract Number: 1459
    Bone Erosion Volume Changes Measured By HR-pQCT at 3-Months after Initiation of Anti-TNF Treatment Predicted Erosion Volume Changes at 1-Year in RA
  • Abstract Number: 485
    Bone Loss in Different Sites over Time in Patients with Rheumatoid Arthritis
  • Abstract Number: 1597
    Bone Mineral Density and Serum Biomarkers of Bone Turnover in Ankylosing Spondylitis Patients Treated with Secukinumab: 2-Year Data from the Pivotal Phase 3 Study
  • Abstract Number: 956
    Bone Mineral Density Is a Causal Risk Factor for Knee and Hip Osteoarthritis: A Population-Based and Mendelian Randomization Study in the UK Biobank
  • Abstract Number: 2639
    Bone Mineral Density Is Not Associated with Osteoporotic Fractures in Premenopausal Women and Men < 50 Years Old with Systemic Lupus Erythematosus
  • Abstract Number: 2259
    BONE Sarcoidosis: A French Case Control Study
  • Abstract Number: 2701
    Botulinum Toxin in the Management of Raynaud’s Phenomenon
  • Abstract Number: 661
    Bridging the Gap between Symptom Onset and Diagnosis in Axial Spondyloarthritis
  • Abstract Number: 526
    Bronchiectasis in RA Is a Crucial Risk Factor of Hospitalised Pneumonia Associated with Bdmards As Well As Interstitial Lung Disease
  • Abstract Number: 2099
    Bruton’s Tyrosine Kinase (BTK) Inhibition Modulates Multiple Cell Types Instrumental in the Pathogenesis of Lupus Nephritis
  • Abstract Number: 2173
    Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis in Biologic-Naïve Patients in the United Kingdom
  • Abstract Number: 300
    Built-in-Electronic-Medical-Record Disease Activity Calculators and Treat-to-Target in Rheumatoid Arthritis
  • Abstract Number: 1755
    Burden of Illness Associated with Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly Churg-Strauss Syndrome): Evidence from a Managed Care Database in the United States
  • Abstract Number: 288
    Burden of Illness of Treating Patients with Pemphigus vulgaris
Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences